-Lisa M Demeter Researcher Activity Profile

Research Author Detailed Information 

Lisa M Demeter Publication Rate By Year

Lisa M Demeter has published 2 paper(s) in 2007, 4 paper(s) in 2008, for a total of 6 research publications in total.

Lisa M Lm Demeter Author Information

LAST NAME: demeter

FIRST NAME: Lisa M

INITIALS: lm

AFFILIATION:

Papers

Lisa M Demeter's Publication Record

1. Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. Year Published: 2007
AIDS Clinical Research Unit (R-60A), Department of Medicine, University of Miami School of Medicine, 1800 NW 10th Avenue, Miami, FL 33136, USA. mfischl@med.miami.edu
2. Clinical significance of human immunodeficiency virus type 1 replication fitness. Year Published: 2007
Infectious Diseases Division, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
3. Association of Efavirenz Hypersusceptibility with Virologic Response in ACTG 368, a Randomized Trial of Abacavir (ABC) in Combination with Efavirenz (EFV) and Indinavir (IDV) in HIV-Infected Subjects with Prior Nucleoside Analog Experience. Year Published: 2008
University of Rochester, Rochester, New York, USA.
4. The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients. Year Published: 2008
Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
5. Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. Year Published: 2008
University of Rochester, Rochester, New York 14642, USA. lisa_demeter@urmc.rochester.edu
6. The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients. Year Published: 2008
Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA. lisa_demeter@urmc.rochester.edu